Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

10,192 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NVAXNovavax$7.72$1.27B-16.7821.77%HoldUnlock the NVAX analyst price target with TipRanks PremiumNVAXUnlock the NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$8.87$1.52B-7.1063.05%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumNVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.70$800.27M-5.27-32.93%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumNVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$10.47$3.42B-21.81190.03%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumNVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.74$521.36M-3.28-48.82%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumNVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NVAXNovavax7.721.2519.32%
VIRVir Biotechnology8.873.1956.16%
ORICOric Pharmaceuticals7.70-3.92-33.73%
ABCLAbCellera Biologics10.476.96198.29%
SANASana Biotechnology1.74-1.55-47.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts